Fumitaka Shimizu

Sarcopenia is a poor prognostic factor of castration-resistant prostate cancer treated with docetaxel therapy

Ayako Ohtaka, Hiroaki Aoki, Masayoshi Nagata et al. · Prostate International · 2018 · 57 citations · Full text

Medicine, Oncology, Urology +16

Stone Attenuation Value and Cross-Sectional Area on Computed Tomography Predict the Success of Shock Wave Lithotripsy

Michio Tanaka, Eisuke Yokota, Yoichiro Toyonaga et al. · Korean journal of urology · 2013 · 43 citations · Full text

Medicine, Surgery, Urology +15

Gut environment changes due to androgen deprivation therapy in patients with prostate cancer

Akimasa Kure, Tomoya Tsukimi, Chiharu Ishii et al. · Prostate Cancer and Prostatic Diseases · 2022 · 31 citations

Medicine, Endocrinology, Oncology +16

Impact of Dry Ejaculation Caused by Highly Selective α1A-blocker: Randomized, Double-blind, Placebo-controlled Crossover Pilot Study in Healthy Volunteer Men

Fumitaka Shimizu, Masataka Taguri, Yoshiko Harada et al. · The Journal of Sexual Medicine · 2010 · 27 citations

Medicine, Pharmacotherapy, Urology +13

Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-muscle Invasive Bladder Cancer in Asia

Takeshi Ieda, Satoru Muto, Fumitaka Shimizu et al. · EBioMedicine · 2016 · 25 citations · Full text

Medicine, Oncology, Urology +10